Correlation Between AP Mller and Genmab AS
Specify exactly 2 symbols:
By analyzing existing cross correlation between AP Mller and Genmab AS, you can compare the effects of market volatilities on AP Mller and Genmab AS and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in AP Mller with a short position of Genmab AS. Check out your portfolio center. Please also check ongoing floating volatility patterns of AP Mller and Genmab AS.
Diversification Opportunities for AP Mller and Genmab AS
Excellent diversification
The 3 months correlation between MAERSK-B and Genmab is -0.55. Overlapping area represents the amount of risk that can be diversified away by holding AP Mller and Genmab AS in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Genmab AS and AP Mller is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on AP Mller are associated (or correlated) with Genmab AS. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Genmab AS has no effect on the direction of AP Mller i.e., AP Mller and Genmab AS go up and down completely randomly.
Pair Corralation between AP Mller and Genmab AS
Assuming the 90 days trading horizon AP Mller is expected to generate 2.93 times less return on investment than Genmab AS. In addition to that, AP Mller is 1.04 times more volatile than Genmab AS. It trades about 0.04 of its total potential returns per unit of risk. Genmab AS is currently generating about 0.12 per unit of volatility. If you would invest 176,900 in Genmab AS on September 10, 2025 and sell it today you would earn a total of 24,100 from holding Genmab AS or generate 13.62% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
AP Mller vs. Genmab AS
Performance |
| Timeline |
| AP Mller |
| Genmab AS |
AP Mller and Genmab AS Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with AP Mller and Genmab AS
The main advantage of trading using opposite AP Mller and Genmab AS positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if AP Mller position performs unexpectedly, Genmab AS can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Genmab AS will offset losses from the drop in Genmab AS's long position.| AP Mller vs. Erria AS | AP Mller vs. Dampskibsselskabet Norden AS | AP Mller vs. Vestas Wind Systems | AP Mller vs. DFDS AS |
| Genmab AS vs. Coloplast AS | Genmab AS vs. Bavarian Nordic | Genmab AS vs. Zealand Pharma AS | Genmab AS vs. ALK Abell AS |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Other Complementary Tools
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |